| Vatalanib studied in …STUDIED_INderived25 of 25show fewer |
|---|
| → studied in | NCT00655655Phase 1 · completed Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors · 25 trials list this drug (0 active) | — | — | Adult Solid Neoplasm,Melanoma,Cutaneous Merkel Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00358163Phase 1 · terminated Trial of PTK787/ZK 222584 Plus Paclitaxel · 25 trials list this drug (0 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00615160Phase 1/Phase 2 · terminated PTK/ZK in Disseminated Malignant Melanoma · 25 trials list this drug (0 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00056459Phase 3 · completed Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer. · 25 trials list this drug (0 active) | — | — | Colorectal Neoplasm,Colon Neoplasm,Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00390000Phase 1 · completed Vatalanib and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors · 25 trials list this drug (0 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00348790Phase 2 · completed Vatalanib in Treating Patients With Recurrent or Progressive Meningioma · 25 trials list this drug (0 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00268918Phase 1 · completed Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients · 25 trials list this drug (0 active) | — | — | Malignant Breast Neoplasm,Malignant Peritoneal Neoplasm,Malignant Fallopian Tube Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00052013Phase 2 · completed Treatment of Von Hippel-Lindau (VHL)-Related Hemangioblastoma With PTK787/ZK 222584 · 25 trials list this drug (0 active) | — | — | Retinal Hemangioblastoma,Central Nervous System Hemangioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00056446Phase 3 · completed Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer · 25 trials list this drug (0 active) | — | — | Colorectal Neoplasm,Colon Neoplasm,Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00072475Phase 2 · completed Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes · 25 trials list this drug (0 active) | — | — | Leukemia,Myelodysplastic Syndrome,Myelodysplastic/Myeloproliferative Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00053885Phase 2 · completed PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma · 25 trials list this drug (0 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00303732Phase 1 · completed Vatalanib and Everolimus in Treating Patients With Advanced Solid Tumors · 25 trials list this drug (0 active) | — | — | Adult Solid Neoplasm,Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00216047Phase 1/Phase 2 · terminated PTK787 + Trastuzumab for HER2 Overexpressing Metastatic Breast Cancer · 25 trials list this drug (0 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00387933Phase 1 · completed Imatinib Mesylate, Vatalanib, and Hydroxyurea in Treating Patients With Recurrent or Relapsed Malignant Glioma · 25 trials list this drug (0 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00227773Phase 2 · withdrawn Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors · 25 trials list this drug (0 active) | — | — | Digestive System Neuroendocrine Tumor G1,Pancreatic Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00134355Phase 2 · completed Study of PTK787 in the Treatment of Patients With Non-Metastatic Androgen Independent Prostate Cancer · 25 trials list this drug (0 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00160043Phase 2 · completed Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non Small Cell Lung Cancer. · 25 trials list this drug (0 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00511043Phase 2 · terminated PTK787 in Refractory or Relapsed Diffuse Large Cell Lymphoma · 25 trials list this drug (0 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00240162Phase 2 · terminated PTK/ZK as Post Transplant Maintenance Therapy in Patients With Multiple Myeloma · 25 trials list this drug (0 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00185588Phase 1/Phase 2 · completed Phase 1-2 Vatalanib and Gemcitabine in Advanced Pancreatic Cancer · 25 trials list this drug (0 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00385853Phase 1 · completed PTK787/ZK 222584 in Combination With Temozolomide and Radiation in Patients With Glioblastoma Taking Enzyme-Inducing Anti-Epileptic Drugs · 25 trials list this drug (0 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00563823Phase 2 · completed Vatalanib in Treating Patients With Metastatic Cutaneous Melanoma That Cannot be Removed by Surgery · 25 trials list this drug (0 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00293371Phase 1/Phase 2 · terminated Docetaxel, Prednisone, and Vatalanib in Treating Patients With Advanced Prostate Cancer · 25 trials list this drug (0 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00128700Phase 1/Phase 2 · completed Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme · 25 trials list this drug (0 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00590343Phase 2 · completed Safety and Efficacy Study of PTK787/ZK222584 to Treat Metastatic Neuroendocrine Tumors · 25 trials list this drug (0 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |